Tsubota Laboratory Incorporated
4890株式会社坪田ラボ
Latest half-year results
First half · fiscal year to 2026-03 · filed 2025-11-12For the first half of the fiscal year to 2026-03: Revenue ¥0.1 billion (-78.9% YoY), Ordinary income ¥-0.4 billion (-639.9% YoY), Net income ¥-0.3 billion (-844.4% YoY).
| This period | Year on year | |
|---|---|---|
| Revenue | ¥103m | -78.9% |
| Ordinary profit | −¥351m | -639.9% |
| Net profit to owners | −¥334m | -844.4% |
From the securities report on EDINET, which states no forecast. History via /v1/companies/4890/earnings-releases.
Financials
Japan GAAP · non-consolidated · fiscal year to 2026-03-31- Revenue
- ¥200m
- Net income
- −¥762m
- ROE
- —
- Equity ratio
- 65.5%
- Dividend / share
- —
- Employees
- 22
| Fiscal year | Revenue | Net income | Total assets | Net assets | ROE | EPS | Operating CF |
|---|---|---|---|---|---|---|---|
| 2026-03-31 | ¥200m | −¥762m | ¥1,319m | ¥864m | — | ¥-29.58 | −¥578m |
| 2025-03-31 | ¥1,357m | ¥206m | ¥2,503m | ¥1,587m | 13.9% | ¥8.04 | −¥318m |
| 2024-03-31 | ¥674m | −¥641m | ¥2,295m | ¥1,367m | — | ¥-25.15 | −¥301m |
| 2023-03-31 | ¥955m | ¥90m | ¥2,673m | ¥1,950m | 6.7% | ¥3.66 | ¥28m |
| 2022-03-31 | ¥641m | ¥153m | ¥1,618m | ¥744m | 23.0% | ¥6.77 | ¥655m |
Indicators
Computed by us from filings · fiscal year to 2026-03-31| Metric | Value | Percentile among listed companies |
|---|---|---|
| ROE, % | — | — |
| Ordinary margin | -3.8042 | 0.6 |
| Equity ratio, % | 65.5 | 66.9 |
| Revenue growth | -0.8526 | 0.2 |
| Net income growth | -4.7023 | 2.4 |
| Operating cash flow / assets | -0.4382 | 0.8 |
Results wording balance: +1.00. Proprietary text method; it describes the wording only and does not interpret context.
Interest example: if all ¥69m of reported debt repriced by 50 basis points, a year's interest would rise by ¥0m. Our arithmetic only, not a forecast: fixed-rate debt and hedges are ignored.
Via /v1/companies/4890/indicators. Descriptive figures, not a rating and not investment advice.
From other filings
As the company states themSegments, votes and tender offers
Stated in EDINET filings/v1/companies/4890/votingOwnership changes
All companies →- 2026-06-19
individual filer disclosed a 18.63% stake in Tsubota Laboratory Incorporated (4890), crossing the 5% reporting threshold.
- 2026-06-19
Holdings of individual filer in Tsubota Laboratory Incorporated (4890) moved above 10% (new -> 18.63%).
- 2025-09-02
individual filer filed a correction to a 5% report on Tsubota Laboratory Incorporated (4890).
- 2025-08-29
individual filer filed a correction to a 5% report on Tsubota Laboratory Incorporated (4890).
- 2025-08-28
individual filer reduced holdings in Tsubota Laboratory Incorporated (4890) to 59.05% from 60.49%.
- 2024-11-18
individual filer filed a correction to a 5% report on Tsubota Laboratory Incorporated (4890).
- 2024-11-15
individual filer reduced holdings in Tsubota Laboratory Incorporated (4890) to 60.49% from 62.14%.
- 2024-10-07
individual filer reduced holdings in Tsubota Laboratory Incorporated (4890) to 62.14% from 62.95%.
- 2023-08-23
individual filer reduced holdings in Tsubota Laboratory Incorporated (4890) to 62.95% from 64.25%.
- 2023-01-24
individual filer reduced holdings in Tsubota Laboratory Incorporated (4890) to 64.25% from 64.66%.
Trades by 5% holders
From the 60-day trade tables in 5% reports| Holder | Period | Net shares | Net % of shares | Avg. filed price | Range |
|---|---|---|---|---|---|
| individual filer | 2026-06-17 – 2026-06-17 | +5,904,600 | +18.63pt | — | — |
| individual filer | 2022-06-23 – 2025-08-21 | -2,077,900 | −8.09pt | ¥432.4 | ¥432–432 |
Net shares and the average are our calculations. Prices are filed prices as stated by the filer, mostly for off-market trades; they are not market prices. Stock lending, custody transfers and option exercises are excluded from net shares. Every row via /v1/companies/4890/trades.
5% filings
Large shareholding reports on 4890| Filed | Filer | Stake | Change | Stated purpose |
|---|---|---|---|---|
| 2026-06-19 | individual filer | 18.63% | — | pure investment |
| 2025-09-02 | individual filer | 59.26% | −1.23pt | management participation |
| 2025-08-29 | individual filer | 59.26% | −1.23pt | management participation |
| 2025-08-28 | individual filer | 59.05% | −1.44pt | management participation |
| 2024-11-18 | individual filer | 60.49% | −1.65pt | management participation |
| 2024-11-15 | individual filer | 60.49% | −1.65pt | management participation |
| 2024-10-07 | individual filer | 62.14% | −0.81pt | management participation |
| 2023-08-23 | individual filer | 62.95% | −1.30pt | management participation |
| 2023-01-24 | individual filer | 64.25% | −0.41pt | management participation |
| 2022-07-22 | individual filer | 64.66% | −2.26pt | management participation |
Cross-shareholdings
From the annual report's status of shareholdings- Listed strategic holdings
- — issues
- Book value
- —
- Sold in the year
- — — issues
- Bought in the year
- — — issues
- Mutual, both reports
- 0
- Held by listed cos.
- 2
Held by: ROHTO PHARMACEUTICAL CO.,LTD. 4527, JINS HOLDINGS Inc. 3046
Purposes, all holdings and mutual flags via /v1/companies/4890/cross-holdings. Share changes include stock splits.
Major shareholders
As of fiscal year end 2026-03-31| Shareholder | Shares | Ratio |
|---|---|---|
| individual holder | 11,923,700 | 46.23% |
| 株式会社坪田 | 3,200,000 | 12.41% |
| individual holder | 1,840,000 | 7.13% |
| ロート製薬株式会社 | 640,000 | 2.48% |
| individual holder | 306,200 | 1.19% |
| 大和証券株式会社 | 260,500 | 1.01% |
| 合同会社マーズ | 250,000 | 0.97% |
| 株式会社ジンズホールディングス | 220,000 | 0.85% |
| individual holder | 219,800 | 0.85% |
| モルガン・スタンレーＭＵＦＧ証券株式会社 | 174,600 | 0.68% |
Get this as JSON
GET /v1/companies/4890
GET /v1/companies/4890/financials
GET /v1/companies/4890/details
GET /v1/companies/4890/segments
GET /v1/companies/4890/voting
GET /v1/companies/4890/tender-offers
GET /v1/companies/4890/indicators
GET /v1/companies/4890/earnings-releases
GET /v1/events?ticker=4890
GET /v1/companies/4890/trades
GET /v1/companies/4890/cross-holdings
GET /v1/companies/4890/brief